Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29175194 | 1.00 | L3MBTL1 (0.52) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL2112334 | 0.87 | CYP1A2 (0.55) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL2915704 | 0.87 | CYP1A2 (0.55) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL2112335 | 0.87 | CYP1A2 (0.55) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL8198615 | 0.85 | MAPT (0.55) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL6861005 | 0.84 | L3MBTL1 (0.58) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL103981 | 0.84 | L3MBTL1 (0.53) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL5207536 | 0.84 | MAPT (0.58) | KMT2APOLBCYP1A2GAAMAPT | |
| SCHEMBL3289218 | 0.84 | MAPT (0.58) | KMT2APOLBCYP1A2GAAMAPT | |
| SCHEMBL7561253 | 0.84 | MAPT (0.58) | KMT2APOLBCYP1A2GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143439-A | Bio-based flame retardant and application thereof in polylactic acid and/or polyhydroxyalkanoate | 中国科学院宁波材料技术与工程研究所 | 2023-12-01 | — | — | CN | claimed |
| CN-119978575-A | Ageing-resistant emulsion and processing technology thereof | 温州佳盛乳胶制品有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-118681567-A | Preparation of difunctional ternary metal catalyst CuZr/CoOx and method for hydrogenation of ethyl levulinate | 南京林业大学 | 2024-09-24 | — | — | CN | disclosed |
| US-20240239801-A1 | PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Université de Montréal (CA) | 2024-07-18 | — | — | US | disclosed |
| CN-115055195-B | Dual-functional catalyst for ethyl levulinate hydrogenation reaction | 清华大学 | 2024-07-09 | — | — | CN | disclosed |
| EP-2277597-B2 | Reductive colour removal | HENKEL AG & CO KGAA (DE) | 2024-06-26 | — | — | EP | disclosed |
| US-11993625-B2 | Calicheamicin derivatives and antibody drug conjugates thereof | PFIZER, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| CN-113652407-B | Carbonyl reductase mutant and application thereof in asymmetric synthesis of chiral compound | 浙江工业大学 | 2024-01-16 | — | — | CN | disclosed |
| CN-117177975-A | Pyrimido [5,4, D ] pyrimidine compounds, compositions comprising the same and uses thereof | 蒙特利尔大学 | 2023-12-05 | — | — | CN | disclosed |
| CN-117143439-A | Bio-based flame retardant and application thereof in polylactic acid and/or polyhydroxyalkanoate | 中国科学院宁波材料技术与工程研究所 | 2023-12-01 | — | — | CN | disclosed |
| US-4801704-A | PENICILLINS | HOFFMAN-LA ROCHE INC. (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0288102-A1 | Novel 2 beta, 16beta-diamino-androstanes | AKZO N.V. (NL) | 1988-10-26 | — | — | EP | disclosed |
| US-4751246-A | ALPHA(AMINOALKYL)-4-HYDROXY-3-(ALKYLSULFINYL) BENZENEMETHANOL AND 2-(4-HYDROXY-3-(ALKYLSULFINYL) PHENYL)ETHYLAMINE-HYPOTENSIVE AGENTS | STERLING DRUG INC. (US) | 1988-06-14 | — | — | US | disclosed |
| EP-0206000-A1 | (2,3)-Alpha-methylenepenam-3-carboxylic acids and derivatives thereof | F. HOFFMANN-LA ROCHE AG (CH) | 1986-12-30 | — | — | EP | disclosed |
| US-4560701-A | ANTIINFLAMMATORY, ANALGESIC AGENTS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1985-12-24 | — | — | US | disclosed |
| US-4452816-A | HYPOTENSIVE AND ANTIARRHYTHMIA AGENTS | STERLING DRUG INC. (US) | 1984-06-05 | — | — | US | disclosed |
| US-4374149-A | HYPOTENSIVE AGENT AND VASODILATOR | STERLING DRUG INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4287201-A | CONTAINING A 2-(SUBSTITUTED PHENYLIMINO)IMIDAZOLIDINE COMPOUND | MERCK & CO., INC. (US) | 1981-09-01 | — | — | US | disclosed |
| US-4117014-A | PROSTAGLANDIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1978-09-26 | — | — | US | disclosed |
| US-4064139-A | TRANQUILIZERS, ANTICONVULSANTS, MUSCLE RELAXANTS, ANTI-PARKINSON'S DISEASE | MERCK & CO., INC. (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11993625-B2 | Calicheamicin derivatives and antibody drug conjugates thereof | STT3A, CLSPN, STT3B | L3MBTL1 4739/4885KMT2A 3063/4885POLB 4306/4885 |
| US-20240239801-A1 | PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | NRAS, BRAF, KRAS | L3MBTL1 2913/4885KMT2A 2665/4885POLB 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.